Showing results (121-130 of 140) with videos related to
Sort By:
Pageof 14
ACS Biomaterials Science & Engineering|March 30, 2022
Development of an Intranasal Gel for the Delivery of a Broadly Acting Subunit Influenza VaccineDevika M Varma, Cole J Batty, Rebeca T Stiepel, et al.ACS Nano|January 15, 2025
Induction of Antigen-Specific Tolerance in a Multiple Sclerosis Model without Broad ImmunosuppressionRebeca T Stiepel, Sean R Simpson, Nicole Rose Lukesh, et al.Frontiers in Immunology|April 10, 2023
Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpGLuis Ontiveros-Padilla, Cole J Batty, Dylan A Hendy, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2017
PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune EncephalomyelitisLindsay M Webb, Stephanie A Amici, Kyle A Jablonski, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 25, 2017
A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccinationRobert D Junkins, Matthew D Gallovic, Brandon M Johnson, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2021
STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory PathwaysBrandon M Johnson, Toru Uchimura, Matthew D Gallovic, et al.Bioengineering & Translational Medicine|March 4, 2024
Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populationsDylan A Hendy, Erik S Pena, Luis Ontiveros-Padilla, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
Novel compounds derived from AR-12 that demonstrate host-directed clearance of intracellular <i>Salmonella enterica</i> Serovar TyphimuriumElizabeth G Graham-Gurysh, M Shamim Hasan Zahid, Devika M Varma, et al.JCI Insight|November 16, 2018
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancerNing Cheng, Rebekah Watkins-Schulz, Robert D Junkins, et al.RSC Pharmaceutics|June 12, 2026
Dual-adjuvant mucosal vaccine leveraging mast cell and TLR9 agonists for protection against poxvirus infectionConnor T Murphy, Grace L Williamson, Luis Ontiveros-Padilla, et al.Pageof 14